Authors:
Bittmann, I
Dose, T
Baretton, GB
Muller, C
Schwaiblmair, M
Kur, F
Lohrs, U
Citation: I. Bittmann et al., Cellular chimerism of the lung after transplantation - An interphase cytogenetic study, AM J CLIN P, 115(4), 2001, pp. 525-533
Authors:
Peiro, G
Diebold, J
Mayr, D
Baretton, GB
Kimmig, R
Schmidt, M
Lohrs, U
Citation: G. Peiro et al., Prognostic relevance of hMLH1, hMSH2, and BAX protein expression in endometrial carcinoma, MOD PATHOL, 14(8), 2001, pp. 777-783
Authors:
Aust, DE
Terdiman, TP
Willenbucher, RF
Chew, K
Ferrell, L
Florendo, C
Molinaro-Clark, A
Baretton, GB
Lohrs, U
Waldman, FM
Citation: De. Aust et al., Altered distribution of beta-catenin, and its binding proteins E-cadherin and APC, in ulcerative colitis-related colorectal cancers, MOD PATHOL, 14(1), 2001, pp. 29-39
Authors:
Lebeau, A
Deimling, D
Kaltz, C
Sendelhofert, A
Iff, A
Luthardt, B
Untch, M
Lohrs, U
Citation: A. Lebeau et al., HER-2/neu analysis in archival tissue samples of human breast cancer: Comparison of immunohistochemistry and fluorescence in situ hybridization, J CL ONCOL, 19(2), 2001, pp. 354-363
Authors:
Peiro, G
Diebold, J
Baretton, GB
Kimmig, R
Lohrs, U
Citation: G. Peiro et al., Cellular apoptosis susceptibility gene expression in endometrial carcinoma: Correlation with Bcl-2, Bax, and caspase-3 expression and outcome, INT J GYN P, 20(4), 2001, pp. 359-367
Citation: C. Zietz et al., Inverse relation of Fas-ligand and tumor-infiltrating lymphocytes in angiosarcoma - Indications of apoptotic tumor counterattack, AM J PATH, 159(3), 2001, pp. 963-970
Authors:
Huss, R
Haas, C
Herrmann, M
Kalden, JR
Lohrs, U
Citation: R. Huss et al., Impairment of genomic DNA binding to a putative dysfunctional receptor on erythrocytes independent of complement and antibodies in systemic lupus erythematosus, VIRCHOWS AR, 437(4), 2000, pp. 380-387
Citation: C. Stoll et al., Prognostic significance of apoptosis and associated factors in oral squamous cell carcinoma, VIRCHOWS AR, 436(2), 2000, pp. 102-108
Authors:
Schaller, UC
Mueller, AJ
Bosserhoff, AK
Haraida, S
Lohrs, U
Buettner, R
Kampik, A
Citation: Uc. Schaller et al., Melanoma inhibitory activity (MIA). Evaluation of a novel tumorassociated antigen as a serum marker for uveal Melanoma, OPHTHALMOLO, 97(6), 2000, pp. 429-432
Authors:
Ihrler, S
Baretton, GB
Menauer, F
Blasenbreu-Vogt, S
Lohrs, U
Citation: S. Ihrler et al., Sjogren's syndrome and MALT lymphomas of salivary glands: A DNA-cytometricand interphase-cytogenetic study, MOD PATHOL, 13(1), 2000, pp. 4-12
Authors:
Ihrler, S
Zietz, C
Sendelhofert, A
Menauer, F
Blasenbreu-Vogt, S
Lohrs, U
Citation: S. Ihrler et al., Differential diagnosis of lymphoepithelial lesions of salivary glands. With particular reference to characteristic duct lesions, PATHOLOGE, 21(6), 2000, pp. 424-432
Authors:
Kaltz-Wittmer, C
Klenk, U
Glaessgen, A
Aust, DE
Diebold, J
Lohrs, U
Baretton, GB
Citation: C. Kaltz-wittmer et al., FISH analysis of gene aberrations (MYC, CCND1, ERBB2, RB, and AR) in advanced prostatic carcinomas before and after androgen deprivation therapy, LAB INV, 80(9), 2000, pp. 1455-1464
Authors:
Diebold, J
Mosinger, K
Peiro, G
Pannekamp, U
Kaltz, C
Baretton, GB
Meier, W
Lohrs, U
Citation: J. Diebold et al., 20q13 and cyclin D1 in ovarian carcinomas. Analysis by fluorescence in situ hybridization, J PATHOLOGY, 190(5), 2000, pp. 564-571
Authors:
Stoll, C
Baretton, G
Soost, F
Terpe, HJ
Domide, P
Lohrs, U
Citation: C. Stoll et al., Prognostic importance of the expression of CD44 splice variants in oral squamous cell carcinomas, ORAL ONCOL, 35(5), 1999, pp. 484-489
Authors:
Haas, CJ
Diebold, J
Hirschmann, A
Rohrbach, H
Lohrs, U
Citation: Cj. Haas et al., In serous ovarian neoplasms the frequency of Ki-ras mutations correlates with their malignant potential, VIRCHOWS AR, 434(2), 1999, pp. 117-120
Authors:
Weissbach, L
Bussar-Maatz, R
Lohrs, U
Schubert, GE
Mann, K
Hartmann, M
Dieckmann, KP
Fassbinder, J
Citation: L. Weissbach et al., Prognostic factors in seminomas with special respect to HCG: Results of a prospective multicenter study, EUR UROL, 36(6), 1999, pp. 601-608
Authors:
Rohrbach, H
Haas, CJ
Baretton, GB
Hirschmann, A
Diebold, J
Behrendt, RP
Lohrs, U
Citation: H. Rohrbach et al., Microsatellite instability and loss of heterozygosity in prostatic carcinomas: Comparison of primary tumors, and of corresponding recurrences after androgen-deprivation therapy and lymph-node metastases, PROSTATE, 40(1), 1999, pp. 20-27
Authors:
Lebeau, A
Nerlich, AG
Sauer, U
Lichtinghagen, R
Lohrs, U
Citation: A. Lebeau et al., Tissue distribution of major matrix metalloproteinases and their transcripts in human breast carcinomas, ANTICANC R, 19(5B), 1999, pp. 4257-4264
Citation: C. Zietz et al., An unusual cluster of cases of Castleman's disease during highly active antiretroviral therapy for AIDS, N ENG J MED, 340(24), 1999, pp. 1923-1924
Authors:
Wolff, H
Kunte, C
Messer, G
Rappersberger, K
Held, E
Lohrs, U
Plewig, G
Meurer, M
Citation: H. Wolff et al., Paraneoplastic pemphigus with fatal pulmonary involvement in a woman with a mesenteric Castleman tumour, BR J DERM, 140(2), 1999, pp. 313-316
Authors:
Baretton, GB
Klenk, U
Diebold, J
Schmeller, N
Lohrs, U
Citation: Gb. Baretton et al., Proliferation- and apoptosis-associated factors in advanced prostatic carcinomas before and after androgen deprivation therapy: prognostic significance of p21/WAF1/CIP1 expression, BR J CANC, 80(3-4), 1999, pp. 546-555